Assistant Professor CHALMERS UNIVERSITY OF TECHNOLOGY Gothenburg, Vastra Gotaland, Sweden
De novo protein design for catalysis of any desired therapeutic outcome is a long-standing goal in protein engineering because of the broad spectrum of pharmacological, biotechnological, and clinical spaces. However, translating protein sequence to protein function is currently neither computationally nor experimentally tangible. Here, we develop ProteinGAN, a self-attention-based variant of the generative adversarial network that is able to ‘learn’ natural protein sequence diversity and enables the rapid generation of functional protein therapeutics. ProteinGAN learns the evolutionary relationships of protein sequences directly from the complex multidimensional amino-acid sequence space and creates new, highly diverse sequence variants with natural-like physical properties. Using malate dehydrogenase (MDH) as a template enzyme, we show that 24% (13 out of 55 tested) of the ProteinGAN-generated and experimentally tested sequences are soluble and display MDH catalytic activity in the tested conditions in vitro, including a highly mutated variant of 106 amino-acid substitutions. ProteinGAN therefore demonstrates the potential of artificial intelligence to rapidly generate highly diverse functional proteins within the allowed biological constraints of the sequence space, directly affecting rapid pharmaceutical formulation design and translation
Learning Objectives:
Upon completion, participant will be able to obtain knowledge on artificial intelligent fundamentals.
Upon completion, participant will be able to gather sufficient information on the clinical translational utility of deep learning from a transcriptomic view.
Upon completion, participant will be able to gather sufficient information on the cutting edge solutions to pharmaceutical generation in precision medicine design from a protein engineering perspective